Crocodile: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
Crocodile
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€417,003
2024 · -€583,935+€166,931
Equity
€6.0m
2024 · €6.4m-€417,003
Cash
€658,075
2024 · €645,366+€12,709
Balance sheet total
€7.2m
2024 · €7.7m-€518,003
Largest movements
Assets
- Receivables within one year -€379,162
down €379,162 (-17.4%), from €2.2m to €1.8m
of which Trade receivables: -€378,840
- Tangible fixed assets -€253,327
down €253,327 (-15.0%), from €1.7m to €1.4m
of which Plant, machinery and equipment: -€138,913
- Intangible fixed assets +€142,973
new in 2025: €142,973
Equity and liabilities
- Profit (loss) carried forward -€417,003
down €417,003 (-13.1%), from €3.2m to €2.8m
- Trade debts -€274,268
down €274,268 (-24.7%), from €1.1m to €835,467
- Other debts +€203,500
new in 2025: €203,500
Income statement
- Turnover +€2.1m
up €2.1m (+9.6%), from €22.1m to €24.2m
- Goods and materials +€2.0m
up €2.0m (+9.7%), from €20.3m to €22.3m
of which Purchases: +€1.8m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
-€583,935
Turnover
+€2.1m
Other operating income
+€43,519
Goods and materials
-€2.0m
Services and other goods
-€60,229
Staff costs
-€47,363
Depreciation
-€15,185
Write-downs
+€16,198
Other operating charges
-€19,963
Other operating items
+€100,000
Financial income
+€13,256
Financial charges
-€5,844
Taxes
-€29
Result 2025
-€417,003
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€191,518
Investment
-€178,810
Financing
€0
Cash 2024
€645,366
From operations (derived)
+€191,518
Net result for the year
-€417,003
Depreciation
+€289,164
Stocks and contracts
+€58,152
Receivables within one year
+€379,162
Deferred charges and accrued income
-€16,957
Trade debts
-€274,268
Tax, wage and social debts
-€30,232
Other debts
+€203,500
Investment (derived)
-€178,810
Investment in fixed assets (net)
-€178,810
Cash 2025
€658,075
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €7,743,611 | €7,225,609 | -€518,003 | -6.7% |
| Fixed assets | 21/28 | €1,689,094 | €1,578,740 | -€110,354 | -6.5% |
| Intangible fixed assets | 21 | - | €142,973 | +€142,973 | |
| Tangible fixed assets | 22/27 | €1,689,094 | €1,435,767 | -€253,327 | -15.0% |
| Land and buildings | 22 | €1,083,687 | €998,512 | -€85,175 | -7.9% |
| Plant, machinery and equipment | 23 | €424,852 | €285,938 | -€138,913 | -32.7% |
| Furniture and vehicles | 24 | €180,556 | €151,317 | -€29,239 | -16.2% |
| Current assets | 29/58 | €6,054,518 | €5,646,869 | -€407,649 | -6.7% |
| Stocks and contracts in progress | 3 | €3,216,690 | €3,158,537 | -€58,152 | -1.8% |
| Stocks | 30/36 | €3,216,690 | €3,158,537 | -€58,152 | -1.8% |
| Goods purchased for resale | 34 | €3,216,690 | €3,158,537 | -€58,152 | -1.8% |
| Amounts receivable within one year | 40/41 | €2,180,544 | €1,801,382 | -€379,162 | -17.4% |
| Trade receivables | 40 | €2,180,208 | €1,801,369 | -€378,840 | -17.4% |
| Other amounts receivable | 41 | €335 | €13 | -€322 | -96.1% |
| Cash at bank and in hand | 54/58 | €645,366 | €658,075 | +€12,709 | +2.0% |
| Deferred charges and accrued income | 490/1 | €11,918 | €28,875 | +€16,957 | +142.3% |
| Total equity and liabilities | 10/49 | €7,743,611 | €7,225,609 | -€518,003 | -6.7% |
| Equity | 10/15 | €6,378,604 | €5,961,601 | -€417,003 | -6.5% |
| Contributions | 10/11 | €745,000 | €745,000 | = | 0.0% |
| Capital | 10 | €745,000 | €745,000 | = | 0.0% |
| Issued capital | 100 | €745,000 | €745,000 | = | 0.0% |
| Reserves | 13 | €2,457,654 | €2,457,654 | = | 0.0% |
| Non-distributable reserves | 130/1 | €157,165 | €157,165 | = | 0.0% |
| Legal reserve | 130 | €123,699 | €123,699 | = | 0.0% |
| Other | 1319 | €33,466 | €33,466 | = | 0.0% |
| Tax-exempt reserves | 132 | €346,696 | €346,696 | = | 0.0% |
| Distributable reserves | 133 | €1,953,794 | €1,953,794 | = | 0.0% |
| Profit (loss) carried forward | 14 | €3,175,950 | €2,758,947 | -€417,003 | -13.1% |
| Amounts payable | 17/49 | €1,365,007 | €1,264,008 | -€100,999 | -7.4% |
| Amounts payable after more than one year | 17 | €160 | €160 | = | 0.0% |
| Other amounts payable | 178/9 | €160 | €160 | = | 0.0% |
| Amounts payable within one year | 42/48 | €1,364,847 | €1,263,848 | -€100,999 | -7.4% |
| Trade debts | 44 | €1,109,734 | €835,467 | -€274,268 | -24.7% |
| Suppliers | 440/4 | €1,109,734 | €835,467 | -€274,268 | -24.7% |
| Taxes, remuneration and social security | 45 | €255,113 | €224,881 | -€30,232 | -11.9% |
| Taxes | 450/3 | €67,398 | €36,191 | -€31,207 | -46.3% |
| Remuneration and social security | 454/9 | €187,715 | €188,690 | +€975 | +0.5% |
| Other amounts payable | 47/48 | - | €203,500 | +€203,500 | |
| Operating income | 70/76A | €22,380,467 | €24,586,517 | +€2.2m | +9.9% |
| Turnover | 70 | €22,114,907 | €24,227,438 | +€2.1m | +9.6% |
| Other operating income | 74 | €265,560 | €309,079 | +€43,519 | +16.4% |
| Non-recurring operating income | 76A | €0 | €50,000 | +€50,000 | |
| Operating charges | 60/66A | €23,055,371 | €25,101,873 | +€2.0m | +8.9% |
| Goods for resale, raw materials and consumables | 60 | €20,339,335 | €22,309,296 | +€2.0m | +9.7% |
| Purchases | 600/8 | €20,418,704 | €22,251,143 | +€1.8m | +9.0% |
| Change in stocks: decrease (increase) | 609 | -€79,369 | €58,152 | +€137,522 | |
| Services and other goods | 61 | €1,130,918 | €1,191,147 | +€60,229 | +5.3% |
| Remuneration, social security and pensions | 62 | €1,218,709 | €1,266,072 | +€47,363 | +3.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €273,979 | €289,164 | +€15,185 | +5.5% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €16,198 | €0 | -€16,198 | -100.0% |
| Other operating charges | 640/8 | €26,232 | €46,195 | +€19,963 | +76.1% |
| Non-recurring operating charges | 66A | €50,000 | €0 | -€50,000 | -100.0% |
| Operating profit (loss) | 9901 | -€674,904 | -€515,356 | +€159,547 | +23.6% |
| Financial income | 75/76B | €96,416 | €109,672 | +€13,256 | +13.7% |
| Recurring financial income | 75 | €96,416 | €109,672 | +€13,256 | +13.7% |
| Income from current assets | 751 | - | €4,006 | +€4,006 | |
| Other financial income | 752/9 | €96,416 | €105,666 | +€9,250 | +9.6% |
| Financial charges | 65/66B | €4,738 | €10,582 | +€5,844 | +123.3% |
| Recurring financial charges | 65 | €4,738 | €10,582 | +€5,844 | +123.3% |
| Debt charges | 650 | - | €3,870 | +€3,870 | |
| Other financial charges | 652/9 | €4,738 | €6,712 | +€1,974 | +41.7% |
| Profit (loss) for the period before taxes | 9903 | -€583,226 | -€416,266 | +€166,960 | +28.6% |
| Income taxes | 67/77 | €708 | €737 | +€29 | +4.0% |
| Taxes | 670/3 | €708 | €737 | +€29 | +4.0% |
| Profit (loss) for the period | 9904 | -€583,935 | -€417,003 | +€166,931 | +28.6% |
| Transfer from tax-exempt reserves | 789 | €0 | - | = | |
| Profit (loss) for the period to be appropriated | 9905 | -€583,935 | -€417,003 | +€166,931 | +28.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.